2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases
申请人:Bayer Aktiengesellschaft
公开号:US06344471B1
公开(公告)日:2002-02-05
The present invention relates to novel 2-aminocarbonyl-5(2H)-isoxazolones as selective ligands of a high-affinity binding site of diisopropyl fluorophosphate (DFP) on brain membranes for the prophylaxis and treatment of disorders of the central nervous system, in particular cognitive disorders, depression, schizophrenia and anxiety.
本发明涉及一种新型的2-氨基甲酰基-5(2H)-异噁唑酮,作为选择性配体,用于预防和治疗中枢神经系统疾病,特别是认知障碍、抑郁症、精神分裂症和焦虑症的高亲和力结合位点上的二异丙基氟磷酸酯(DFP)在脑膜上。